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Abstract 
A series of herbal medicines and minerals such as milk thistle, curcumin, sea buckthorn, artichoke and zeolite 
can be used as alternative solutions in scavenging oxygen free radicals incriminated in triggering of liver disease. The 
aim of this study was the therapeutic application of different herbal and mineral preparations with antioxidant properties 
and evaluation of their hepatoprotective potential in the complex therapy management of various types of liver disorders 
diagnosed in dogs and cats. The study was performed between October 2016 – September 2017 on 16 dogs and 4 cats 
of different breeds, sexes and ages which were presented and diagnosed with different degrees of liver failure in Medical 
Clinic of the Faculty of Veterinary Medicine from Iasi. Anamnesis and physical examination have highlighted that the 
clinical onset of liver disease was nonspecific, in most cases, the diagnosis of a liver disorder could be deduced from the 
results of the biochemical tests corroborated with the ultrasound findings. The therapeutic management of liver disease 
has depended on the etiopathology, the degree of biochemical resonance of the cytolytic, cholestatic process and the 
synthesis imbalance in the liver as well as the presence or absence of complications of the liver pathology. Thus, 
according to the established protocol, patients were divided in three groups and they received the basic drug treatment 
in combination with hepatoprotective preparations of vegetal and mineral origin, respectively, milk thistle (silymarin), 
curcumin, sea buckthorn and zeolite. The inclusion of phytotherapy in the complex treatment of liver disease has 
contributed to the normalization of hepatic transaminases and cholestasis parameters. A positive therapeutic result was 
obtained after therapy with antioxidants from vegetable origin in mild and average forms of liver disease. In the final 
stage of the liver disease, treatment with natural hepatoprotective agents had a palliative character with transient 
reduction of clinical signs and temporary improvement of quality of life. 
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Introduction 
In the last decade, a multitude of pharmacotoxicological studies have been carried out in 
animal models and human clinical trials in order to find natural solutions for decontracing adverse 
reactions of synthetic drugs, restoring unbalanced hepatic functions and increasing hepatocyte 
resistance to the action of various harmful factors. The association of allopathic therapies with plant 
supplements is gaining ground to potentiate the therapeutic strategies and prevent adverse effects. 
A series of plant compounds with proven antioxidant principles, such as flavonoids, polyphenols, 
carotenoids complexes, tocopherols, terpene, phytosterols, ascorbic acid, can be used in scavenging 
oxygen free radicals incriminated in triggering liver pathology (Stănescu and al., 2002). Thus, 
numerous studies have concluded that biologically active substances found in certain plants such 
as milk thistle, sea buckthorn, artichoke, curcumin have the role of rebuilding the hepatic cell and 
increasing the ability of the liver to defend against oxidative stress. 
 
Material and methods 
The study was conducted between October 2016 and September 2017 at the Medical Clinic 
of the Faculty of Veterinary Medicine in Iaşi and included 16 patients with clinical signs and 





different ages, sexes and breeds. Patients underwent a clinical, biochemical and ultrasound 
examination. The evaluation of each patient's condition involved the development of an individual 
clinical diagnosis card that included data from the history of the disease (early signs of the disease, 
preexisting or coexisting conditions, potential hepatotoxic treatments, vaccine status, diet) and data 
on the current state of the animal at the time of consultation obtained by general semiological 
methods. Functional liver status was assessed according to basic biochemical syndromes: cytolytic 
(ALT / TGP, AST / TGO), cholestasis (GGT, alkaline phosphatase / ALP) and insufficient 
synthesis function (total protein, urea and serum glucose). 
The ultrasound examination of abdominal organs was performed using Aquila Pro Vet 
with a convex probe of 5 and 7.5 MHz to highlight the changes in size, shape and echogenity of 
the liver, canals and gall bladder, spleen and stomach before and after treatment. 
The therapeutic management of liver disease depended on the etiopatology, the degree of 
biochemical resonance of the cytolytic, cholestatic process and the synthesis imbalance in the liver 
as well as the presence or absence of complications of the liver pathology. Thus, according to the 
established protocol, patients received basic drug therapy in combination with hepatoprotective 
preparations from herbal and mineral origin, respectively, silymarin (milk thistle), curcumin, sea 
buckthorn, artichoke and zeolite (Table 1). 
Table 1 
Herbal and mineral medication used in outpatient / hospital 
treatment of hepatopathies in dogs and cats 
Herbal / mineral product 
Active ingredient Indications 
















Curcumin 350 mg/day/p.o., 1-3 months 






Zeolite 600 mg/animal/day/p.o, 3 months 
 
 
The duration of treatment was between 1 - 3 months, 2-3 times/year. Regarding the classic 
hepatic therapy strategies, it has been used IV fluid therapy with isotonic solutions (0.9% Saline, 
Ringer, glucose 5%), antioxidants (ascorbic acid - vitamin C, tocopherol - vitamin E, N - 
acetylcysteine), vitamins (thiamine, pyridoxine), anti-hemorragic agents (phytomenadione, 
ethamsylate), diuretics (spironolactone and furosemide), antisecretory drugs (H2 antagonists: 
ranitidine, famotidine and proton pump inhibitors: pantoprazole), choleretic agents (dry artichoke 
extract, ursodeoxycholic acid), antibiotics (amoxicillin and clavulanic acid, metronidazole, 
enrofloxacin, third generation cephalosporin: ceftriaxone,), glucocorticoids (prednisone, 
methylprednisolone, dexamethasone), antipyretic (metamizol). 





● Patients with jaundice secundary to an acute toxic hepatitis or parasitic hepatitis 
(babesiosis, dirofilariosis) who received silymarin + sea buckthorn (4 dogs) and silymarin + 
curcumin (2 dogs) for 30 days; 
● Patients with ascitic syndrome as a result of a straight heart failure or a neoplastic process 
(2 dogs), which has been prescribed the combination of silymarin + sea buckthorn + curcumin + 
zeolite for 3 months, 2-3 times/year; 
● Patients with cholestasis syndrome in angiocolites, colangitis, triadites (2 dogs and 4 
cats) who received silymarin + sea buckthorn + artichokes for 30 days. 
 
Results and discussions 
Of the 16 patients diagnosed with different hepatopathies, 14, respectively 10 dogs and 4 
cats of different breeds, sexes and ages responded positively clinically and biochemically to 
therapy with hepatoprotective plant products (Table 2). 
Anamnesis and clinical examination have highlighted that the clinical onset of liver disease 
was nonspecific and included the appearance of a dyspeptic syndrome such as loss of appetite, 
nausea and vomiting, intestinal metheorism, diarrhea or constipation, abdominal colic, various 
degrees of dehydration, discrete to severe weight loss within a few weeks, polyuria / polydipsia, 
hyperkeroma urine, apathy to coma, multiple organ failure, and symptoms of advanced hepatic 
disease such as ascites, jaundice and coagulopathy (bruising, petechiae). In most cases, the 
diagnosis of a liver disorder could be deduced from the paraclinical results corroborated with the 
ultrasound findings. In terms of hepatobiliary pathology in patients following adjuvant therapy 
with herbal active principles have prevailed toxic hepatitis (7/10 dogs), ascites secondary to 
neoplasia or heart failure (2/10 dogs); and in cats have predominated cholangiohepatitis (2/4 cats) 
and triadites (2/4) (Table 2). 
Table 2 
Hepatic biochemical changes (values before and after treatment) in dogs and cats diagnosed with 
different hepatopathies 
ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, GGT 





























Silymarin 150 mg/day, 
1 month 
Sea buckthorn, 




























































2X150 mg /day, 














































































































9 y, 25 kg 
Babesiosis 





































ALT 92 →45 





































































































































































All patients had a positive clinic evolution after administration of different combinations 
of herbal active substances. Thus, asthenic, dyspepsic or algic syndrome have improved in 7-14 
days after administration of hepatoprotective plant products, and the jaundice has relieved after 
approximately one month beyond treatment initiation. Also, in patients who developed a weight 
loss syndrome, the association of sea buckthorn oil with silymarin contributed to the improvement 
in body weight decline as a result of loss of appetite. 
In a patient (Bichon female, 8 years old) with ascites syndrome as a result of a neoplastic 
process associated with congestive heart failure, 2 months after following hepatoprotective herbal 
and mineral products therapy (silymarin + sea buckthorn + curcumin + zeolite) associated with 
weekly therapeutic paracentesis, it seen a marked improvement in the state of health and quality of 
life, with decreasing intensity to disappearance of ascites (Figure 1). In another patient diagnosed 
with hepatobiliary carcinoma and secondary ascites, being at the final stage of the disease, therapy 





clinical signs, temporary improvement of quality of life and biochemical results, corresponded by 





















Dog, Bichon, ♀, 8 years old, diagnosed with mixed ascitic syndrome, clinical and ultrasound 
aspects before (left pictures) and after treatment (right pictures) 
 
In the majority of patients from the three groups diagnosed with different hepatopathies, 
administration of various herbal drugs combinations has been beneficial in the evolution of 
biochemical indices. Thus, in patients diagnosed with cholangiohepatitis or cholestasis who 
received artichoke extract in addition to silymarin and sea buckthorn oil, an improvement of liver 
enzymes was observed and the alkaline phosphatase activity decreased to normal values. 
The reports from medical literature shows that silymarin, sea buckthorn, curcumin and 
artichoke exhibit antioxidant, anti-inflammatory, antifibrotic, cytoprotective, membrane- 
stabilizing, detoxifying and improving liver function synthesis properties (Webster & Cooper, 
2009; Loguercio et al. 2011; He et al., 2015, Colak et al., 2016). Interesting data on the antitumor 
action of these hepatoprotective agents have been reported due to the ability to regulates hepatocyte 
apoptosis and down-regulate gene products involved in profilation of tumor cells, angiogenesis and 
metastasis (Agarwal et al., 2006; López-Lázaro, 2008; Ramos et al., 2014). These effects confirm 







1. The association of various medical plants with allopathic therapy in the complex 
management of liver disease has helped to normalize the activities of hepatic transaminases and 
cholestasis indices, with a high degree of cytoprotection. 
2. A positive therapeutic result was obtained after therapy with antioxidants from herbal 
origin in the mild and average forms of liver disease. 
3. The administration of silymarin + sea buckthorn, silymarin + curcumin or artichoke for 
a period of 14 -30 days in patients with toxic, infectious or gall bladder disease lead to improvement 
of liver function and cytolytic indices, as well as reducing the activity of cholestasis markers. 
4. For end-stage diseases, natural hepatoprotective therapy was palliative, with transient 
diminution of clinical signs and temporary improvement in quality of life. 
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